• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Michelle C. Specht, MD


  • Miller CL, West JA, Bettini AC, Koerner FC, Gudewicz TM, Freer PE, Coopey SB, Gadd MA, Hughes KS, Smith BL, Rafferty E, Specht MC.Surgical excision of radial scars diagnosed by core biopsy may help predict future risk of breast cancer.Breast Cancer Res Treat. 2014 Apr 19.
  • Miller CL, Specht MC, Skolny MN, Horick N, Jammallo LS, O'Toole J, Shenouda MN, Sadek BT, Smith BL, Taghian AG.Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients.Breast Cancer Res Treat. 2014 Feb;144(1):71-7.
  • Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, Shenouda MN, O'Toole JA, MacDonald SM, Specht MC, Taghian AG.The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71.
  • Carp SA, Sajjadi AY, Wanyo CM, Fang Q, Specht MC, Schapira L, Moy B, Bardia A, Boas DA, Isakoff SJ.Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.Biomed Opt Express. 2013;4(12):2911-24.
  • Jammallo LS, Miller CL, Singer M, Horick NK, Skolny MN, Specht MC, O'Toole J, Taghian AG.Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.Breast Cancer Res Treat. 2013 Nov;142(1):59-67.
  • O'Toole J, Jammallo LS, Skolny MN, Miller CL, Elliott K, Specht MC, Taghian AG.Lymphedema following treatment for breast cancer: a new approach to an old problem.Crit Rev Oncol Hematol. 2013 Nov;88(2):437-46.
  • Tang R, Coopey SB, Buckley JM, Aftreth OP, Fernandez LJ, Brachtel EF, Michaelson JS, Gadd MA, Specht MC, Koerner FC, Smith BL.A pilot study evaluating shaved cavity margins with micro-computed tomography: a novel method for predicting lumpectomy margin status intraoperatively.Breast J.;19(5):485-9.
  • Coopey SB, Tang R, Lei L, Freer PE, Kansal K, Colwell AS, Gadd MA, Specht MC, Austen WG, Smith BL.Increasing eligibility for nipple-sparing mastectomy.Ann Surg Oncol. 2013 Oct;20(10):3218-22.
  • Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?.Breast Cancer Res Treat. 2013 Aug;140(3):485-94.
  • Specht MC, Miller CL, Skolny MN, Jammallo LS, O'Toole J, Horick N, Isakoff SJ, Smith BL, Taghian AG.Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.Ann Surg Oncol. 2013 Sep;20(9):2835-41.
  • O'Toole J, Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, Elliott K, Niemierko A, Taghian AG.Cording following treatment for breast cancer.Breast Cancer Res Treat. 2013 Jul;140(1):105-11.
  • Macdonald SM, Patel SA, Hickey S, Specht M, Isakoff SJ, Gadd M, Smith BL, Yeap BY, Adams J, Delaney TF, Kooy H, Lu HM, Taghian AG.Proton Therapy for Breast Cancer After Mastectomy: Early Outcomes of a Prospective Clinical Trial.Int J Radiat Oncol Biol Phys. 2013 Mar 21.
  • Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, Polubriaginof F, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS.The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.Breast Cancer Res Treat. 2012 Nov 2.
  • Ancukiewicz M, Miller CL, Skolny MN, O'Toole J, Warren LE, Jammallo LS, Specht MC, Taghian AG.Erratum to: Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.Breast Cancer Res Treat. 2012 Nov;136(2):623.
  • Coopey SB, Specht MC, Warren L, Smith BL, Winograd JM, Fleischmann K.Use of Preoperative Paravertebral Block Decreases Length of Stay in Patients Undergoing Mastectomy Plus Immediate Reconstruction.Ann Surg Oncol. 2012 Oct 14.
  • Camp MS, Greenup RA, Taghian A, Coopey SB, Specht M, Gadd M, Hughes K, Smith BL.Application of ACOSOG Z0011 Criteria Reduces Perioperative Costs.Ann Surg Oncol. 2012 Sep 26.
  • Pashtan IM, Recht A, Ancukiewicz M, Brachtel E, Abi-Raad RF, D'Alessandro HA, Levy A, Wo JY, Hirsch AE, Kachnic LA, Goldberg S, Specht M, Gadd M, Smith BL, Powell SN, Taghian AG.External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study.Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e271-7.
  • Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, O'Toole J, Coopey SB, Hughes K, Gadd M, Smith BL, Taghian AG.Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.Breast Cancer Res Treat. 2012 Oct;135(3):781-9.
  • Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL.Cost comparison of radiation treatment options after lumpectomy for breast cancer.Ann Surg Oncol. 2012 Oct;19(10):3275-81.
  • Buckley JM, Coopey SB, Sharko J, Polubriaginof F, Drohan B, Belli AK, Kim EM, Garber JE, Smith BL, Gadd MA, Specht MC, Roche CA, Gudewicz TM, Hughes KS.The feasibility of using natural language processing to extract clinical information from breast pathology reports.J Pathol Inform. 2012;3:23.
  • Ancukiewicz M, Miller CL, Skolny MN, O'Toole J, Warren LE, Jammallo LS, Specht MC, Taghian AG.Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.Breast Cancer Res Treat. 2012 Aug;135(1):145-52.
  • Ancukiewicz M, Russell TA, Otoole J, Specht M, Singer M, Kelada A, Murphy CD, Pogachar J, Gioioso V, Patel M, Skolny M, Smith BL, Taghian AG.Standardized Method for Quantification of Developing Lymphedema in Patients Treated for Breast Cancer.Int J Radiat Oncol Biol Phys. 2010 Jun 2.
  • Samphao S, Wheeler AJ, Rafferty E, Michaelson JS, Specht MC, Gadd MA, Hughes KS, Smith BL.Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging.Am J Surg. 2009 Oct;198(4):538-43.
  • Javid SH, Kirstein LJ, Rafferty E, Lipsitz S, Moore R, Rusby JE, Murphy CD, Hughes KS, Specht MC, Taghian AG, Smith BL.Outcome of multiple-wire localization for larger breast cancers: do multiple wires translate into additional imaging, biopsies, and recurrences?.Am J Surg. 2009 Sep;198(3):368-72.
  • Pandharipande PV,Harisinghani MG,Ozanne EM,Specht MC,Hur C,Lee JM,Gazelle GS.Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis.AJR Am J Roentgenol. 2008 Nov;191(5):1308-19.
  • Murphy CD,Lee JM,Drohan B,Euhus DM,Kopans DB,Gadd MA,Rafferty EA,Specht MC,Smith BL,Hughes KS.The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.Cancer. 2008 Dec 1;113(11):3116-20.
  • Murphy CD,Jones JL,Javid SH,Michaelson JS,Nolan ME,Lipsitz SR,Specht MC,Lesnikoski BA,Hughes KS,Gadd MA,Smith BL.Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?.Am J Surg. 2008 Oct;196(4):566-8.
  • Kirstein LJ,Rafferty E,Specht MC,Moore RH,Taghian AG,Hughes KS,Gadd MA,Smith BL.Outcomes of multiple wire localization for larger breast cancers: when can mastectomy be avoided?.J Am Coll Surg. 2008 Sep;207(3):342-6.
  • Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG.Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.J Clin Oncol. 2008 May 1;26(13):2093-8.
  • Miller JC, Rafferty EA, Specht MC, Thrall JH, Lee SI.When is breast magnetic resonance imaging recommended for cancer detection?.J Am Coll Radiol. 2008 Mar;5(3):224-6.
  • Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL.Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.Ann Surg Oncol. 2008 Jan;15(1):268-73.
  • Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B.Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.Ann Surg Oncol. 2007 Sep;14(9):2477-84.
  • Dominguez FJ, Lawrence C, Halpern EF, Drohan B, Grinstein G, Black DM, Smith BL, Gadd MA, Specht M, Kopans DB, Moore RH, Hughes SS, Roche CA, Hughes KS.Accuracy of Self-Reported Personal History of Cancer in an Outpatient Breast Center.J Genet Couns. 2007 Jun;16(3):341-5.
  • Zabicki K, Colbert JA, Dominguez FJ, Gadd MA, Hughes KS, Jones JL, Specht MC, Michaelson JS, Smith BL.Breast Cancer Diagnosis in Women </= 40 versus 50 to 60 Years: Increasing Size and Stage Disparity Compared With Older Women Over Time.Ann Surg Oncol. 2006 Aug;13(8):1072-7.
  • Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ.Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.Ann Surg Oncol. 2005 Aug;12(8):654-9.
  • Specht MC, Fey JV, Borgen PI, Cody HS.Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?.J Am Coll Surg. 2005 Jan;200(1):10-4.
  • Specht MC, Borgen PI, Fey J, Zhang Z, Sclafani L.Personal health behaviors in women who have undergone risk-reducing mastectomy.Am J Surg. 2004 Oct;188(4):448-9.
  • Teng L, Specht MC, Barden CB, Fahey TJ.Antisense hTERT inhibits thyroid cancer cell growth.J Clin Endocrinol Metab. 2003 Mar;88(3):1362-6.
  • Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ.Cyclooxygenase-2 expression in thyroid nodules.J Clin Endocrinol Metab. 2002 Jan;87(1):358-63.